Phase I trials are the first stage of clinical research conducted in humans. These studies are primarily designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a new drug or treatment. In the context of cancer, Phase I trials are crucial for determining the appropriate dosage and identifying any potential side effects of new cancer therapies.
